Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications

Physiological Research

Volumn 54, Issue 1, 2005, Pages 1-16

  Zdychova J ^a   Komers, R ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Akt kinase; Diabetes mellitus; Diabetic vascular complications; Insulin

Indexed keywords

PROTEIN KINASE B;

ANIMAL CELL; CELL FUNCTION; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIUM; ENZYME ACTIVITY; HEMODYNAMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; RAT; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 14944381279     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (111)

1. ALESSIDR, JAMES SR, DOWNES CP, HOLMES AB, GAFFNEY PR, REESE CB, COHEN P: Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 7: 261-269, 1997.
2. BELLACOSA A, CHAN TO, AHMED NN, DATTA K, MALSTROM S, STOKOE D, MCCORMICK F, FENG J, TSICHLIS P: Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17: 313-325, 1998.
3. BERNAL-MIZRACHI E, WEN W, STAHLHUT S, WELLING CM, PERMUTT MA: Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108: 1631-1638, 2001.
4. BHANDARI BK, FELIERS D, DURAISAMY S, STEWART JL, GINGRAS AC, ABBOUD HE, CHOUDHURY GG, SONENBERG N, KASINATH BS: Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells. Kidney Int 59: 866-875, 2001.
5. BIGGS WH, MEISENHELDER J, HUNTER T, CAVENEE WK, ARDEN KC: Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421-7426, 1999.
6. BOTTOMLEY MJ, SALIM K, PANAYOTOU G: Phospholipid-binding protein domains. Biochim Biophys Acta 1436: 165-183, 1998.
7. BURGERING BM, COFFER PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602, 1995.
8. CALERA MR, MARTINEZ C, LIU H, JACK AK, BIRNBAUM MJ, PILCH PF: Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem 273: 7201-7204, 1998.
9. CAMPER-KIRBY D, WELCH S, WALKER A, SHIRAISHI I, SETCHELL KD, SCHAEFER E, KAJSTURA J, ANVERSA P, SUSSMAN MA: Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88: 1020-1027, 2001.
10. CARVALHO E, RONDINONE C, SMITH U: Insulin resistance in fat cells from obese Zucker rats - evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem 206: 7-16, 2000.
11. CHAVAKIS E, DERNBACH E, HERMANN C, MONDORF UF, ZEIHER AM, DIMMELER S: Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103: 2102-2107, 2001.
12. 1 modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation. Am J Physiol 281: H1035-H1039, 2001a.
13. CHEN WS, XU PZ, GOTTLOB K, CHEN ML, SOKOL K, SHIYANOVA T, RONINSON I, WENG W, SUZUKI R, TOBE K, KADOWAKI T, HAY N: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15: 2203-2208, 2001b.
14. CHENG JQ, ALTOMARE DA, KLEIN MA, LEE WC, KRUH GD, LISSY NA, TESTA JR: Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14: 2793-2801, 1997.
15. CHO DH, CHOI YJ, JO SA, JO I: Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) γ-dependent and PPARγ-independent signaling pathways. J Biol Chem 279: 2499-2506, 2004.
16. CHO H, MU J, KIM JK, THORVALDSEN JL, CHU Q, CRENSHAW EB, KAESTNER KH, BARTOLOMEI MS, SHULMAN GI, BIRNBAUM MJ: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292: 1728-1731, 2001.
17. CHRISTIANSEN JS, GAMMELGAARD J, ORSKOV H, ANDERSEN AR, TELMER S, PARVING HH: Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11: 487-490, 1981.
18. CONTRERAS JL, SMYTH CA, BILBAO G, YOUNG CJ, THOMPSON JA, ECKHOFF DE: Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation 74: 1063-1069, 2002.
19. CROSS DA, ALESSI DR, COHEN P, ANDJELKOVICH M, HEMMINGS BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
20. DAVIS RJ: Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
21. DEFRONZO RA, GOLDBERG M, AGUS Z: The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 58: 83-90, 1976.
22. DEL PESO L, GONZALEZ-GARCIA M, PAGE C, HERRERA R, NUNEZ G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689, 1997.
23. DIMMELER S, ASSMUS B, HERMANN C, HAENDELER J, ZEIHER AM: Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 83: 334-341, 1998.
24. DIMMELER S, FLEMING I, FISSLTHALER B, HERMANN C, BUSSE R, ZEIHER AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
25. DIMMELER S, AICHER A, VASA M, MILDNER-RIHM C, ADLER K, TIEMANN M, RUTTEN H, FICHTLSCHERER S, MARTIN H, ZEIHER AM: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397, 2001.
26. DOBRZYNSKI E, MONTANARI D, AGATA J, ZHU J, CHAO J, CHAO L: Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 283: E1291-E1298, 2002.
27. DOWNWARD J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10: 262-267, 1998.
28. DU XL, EDELSTEIN D, DIMMELER S, JU Q, SUI C, BROWNLEE M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108: 1341-1348, 2001.
29. ENDRES M, LAUFS U, HUANG Z, NAKAMURA T, HUANG P, MOSKOWITZ MA, LIAO JK: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885, 1998.
30. ETO M, KOZAI T, COSENTINO F, JOCH H, LUSCHER TF: Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105: 1756-1759, 2002.
31. FELIERS D, DURAISAMY S, FAULKNER JL, DUCH J, LEE AV, ABBOUD HE, CHOUDHURY GG, KASINATH BS: Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int 60: 495-504, 2001.
32. FRANKE TF, KAPLAN DR, CANTLEY LC: PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437, 1997.
33. FREVERT EU, BJORBAEK C, VENABLE CL, KELLER SR, KAHN BB: Targeting of constitutively active phosphoinositide 3-kinase to GLUT4-containing vesicles in 3T3-L1 adipocytes. J Biol Chem 273: 25480-25487, 1998.
34. FU M, ZHU X, WANG Q, ZHANG J, SONG Q, ZHENG H, OGAWA W, DU J, CHEN YE: Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway. Circ Res 89: 1058-1064, 2001.
35. FULTON D, GRATTON JP, MCCABE TJ, FONTANA J, FUJIO Y, WALSH K, FRANKE TF, PAPAPETROPOULOS A, SESSA WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
36. GERBER HP, DIXIT V, FERRARA N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998.
37. GERHARDINGER C, MCCLURE KD, ROMEO G, PODESTA F, LORENZI M: IGF-I mRNA and signaling in the diabetic retina. Diabetes 50: 175-183, 2001.
38. GOETZE S, BUNGENSTOCK A, CZUPALLA C, EILERS F, STAWOWY P, KINTSCHER U, SPENCER-HANSCH C, GRAF K, NURNBERG B, LAW RE, FLECK E, GRAFE M: Leptin induces endothelial cell migration through Akt, which is inhibited by PPARγ-ligands. Hypertension 40: 748-754, 2002.
39. GORIN Y, KIM NH, FELIERS D, BHANDARI B, CHOUDHURY GG, ABBOUD HE: Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 15: 1909-1920, 2001.
40. HAJDUCH E, DARAKHSHAN F, HUNDAL HS: Fructose uptake in rat adipocytes: GLUTS expression and the effects of streptozotocin-induced diabetes. Diabetologia 41: 821-828, 1998.
41. HORI H, SASAOKA T, ISHIHARA H, WADA T, MURAKAMI S, ISHIKIM, KOBAYASHI M: Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51: 2387-2394, 2002.
42. ISHII H, JIROUSEK MR, KOYA D, TAKAGI C, XIA P, CLERMONT A, BURSELL S-E, KERN TS, BALLAS LM, HEATH WF, KING GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKCb inhibitor. Science 272: 728-731, 1996.
43. JIANG G, DALLAS-YANG Q, LIZ, SZALKOWSKI D, LIU F, SHEN X, WU M, ZHOU G, DOEBBER T, BERGER J, MOLLER DE, ZHANG BB: Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARy agonists. Diabetes 51: 2412-2419, 2002.
44. JIANG ZY, LIN YW, CLEMONT A, FEENER EP, HEIN KD, IGARASHI M, YAMAUCHI T, WHITE MF, KING GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104: 447-457, 1999.
45. JOUSSEN AM, POULAKI V, TSUJIKAWA A, QIN W, QAUM T, XU Q, MOROMIZATO Y, BURSELL SE, WIEGAND SJ, RUDGE J, IOFFE E, YANCOPOULOS GD, ADAMIS AP: Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 160: 1683-1693, 2002.
46. KAUFFMANN-ZEH A, RODRIGUEZ-VICIANA P, ULRICH E, GILBERT C, COFFER P, DOWNWARD J, EVAN G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548, 1997.
47. KHWAJA A, RODRIGUEZ-VICIANA P, WENNSTROM S, WARNE PH, DOWNWARD J: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997.
48. KIM AH, KHURSIGARA G, SUN X, FRANKE TF, CHAO MV: Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901, 2001.
49. KIM I, KIM HG, SO JN, KIM JH, KWAK HJ, KOH GY: Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 86: 24-29, 2000.
50. KIM YB, NIKOULINA SE, CIARALDI TP, HENRY RR, KAHN BB: Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741, 1999a.
51. KIM YB, ZHU JS, ZIERATH JR, SHEN HQ, BARON AD, KAHN BB: Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 48: 310-320, 1999b.
52. KING GL, GOODMAN AD, BUZNEY S, MOSES A, KAHN CR: Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75: 1028-1036, 1985.
53. KOHN AD, SUMMERS SA, BIRNBAUM MJ, ROTH RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996.
54. KOTANI K, OGAWA W, MATSUMOTO M, KITAMURA T, SAKAUE H, HINO Y, MIYAKE K, SANO W, AKIMOTO K, OHNO S, KASUGA M: Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18: 6971-6982, 1998.
55. KROOK A, KAWANO Y, SONG XM, EFENDIC S, ROTH RA, WALLBERG-HENRIKSSON H, ZIERATH JR: Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46: 2110-2114, 1997.
56. KROOK A, ROTH RA, JIANG XJ, ZIERATH JR, WALLBERG-HENRIKSSON H: Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47: 1281-1286, 1998.
57. KUREISHI Y, LUO Z, SHIOJIMA I, BIALIK A, FULTON D, LEFER DJ, SESSA WC, WALSH K: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010, 2000.
58. LAVIOLA L, BELSANTI G, DAVALLI AM, NAPOLI R, PERRINI S, WEIR GC, GIORGINO R, GIORGINO F: Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 50: 2709-2720, 2001.
59. LAWRENCE JC, ROACH PJ: New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46: 541-547, 1997.
60. LIMBOURG FP, HUANG Z, PLUMIER JC, SIMONCINI T, FUJIOKA M, TUCKERMANN J, SCHUTZ G, MOSKOWITZ MA, LIAO JK: Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110: 1729-1738, 2002.
61. LUO Z, FUJIO Y, KUREISHI Y, RUDIC RD, DAUMERIE G, FULTON D, SESSA WC, WALSH K: Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest 106: 493-499, 2000.
62. MARLETTA MA: Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated? Trends Biochem Sci 26: 519-521, 2001.
63. MCVEIGH GE, BRENNAN GM, JOHNSTON GD, MCDERMOTT BJ, MCGRATH LT, ANDREWS JW, HAYES JR: Impaired endothelium-dependent and independent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776, 1992.
64. kip1. Nature 404: 782-787, 2000.
65. MEYER MM, LEVIN K, GRIMMSMANN T, BECK-NIELSEN H, KLEIN HH: Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Diabetologia 45: 813-822, 2002a.
66. MEYER MM, LEVIN K, GRIMMSMANN T, PERWITZ N, EIRICH A, BECK-NIELSEN H, KLEIN HH: Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. Diabetes 51: 2691-2697, 2002b.
67. MIZUTANI M, KERN TS, LORENZI M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890, 1996.
68. NADLER ST, STOEHR JP, RABAGLIA ME, SCHUELER KL, BIRNBAUM MJ, ATTIE AD: Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice. Am J Physiol 281: E1249-E1254, 2001.
69. NAKAMURA M, BARBER AJ, ANTONETTI DA, LANOUE KF, ROBINSON KA, BUSE MG, GARDNER TW: Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem 276: 43748-43755, 2001.
70. NISHIKAWA T, EDELSTEIN D, DU XL, YAMAGISHI S, MATSUMURA T, KANEDA Y, YOREK MA, BEEBE D, OATES PJ, HAMMES HP, GIARDINO I, BROWNLEE M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
71. OGIHARA T, ASANO T, ANDO K, SAKODA H, ANAI M, SHOJIMA N, ONO H, ONISHI Y, FUJISHIRO M, ABE M, FUKUSHIMA Y, KIKUCHI M, FUJITA T: High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40: 83-89, 2002.
72. OKADA T, KAWANO Y, SAKAKIBARA T, HAZEKI O, UI M: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269: 3568-3573, 1994.
73. ORLOWSKIRZ, BALDWIN AS: NF-κB as a therapeutic target in cancer. Trends Mol Med 8: 385-9, 2002.
74. OZES ON, MAYO LD, GUSTIN JA, PFEFFER SR, PFEFFER LM, DONNER DB: NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999.
75. OZES ON, AKCA H, MAYO LD, GUSTIN JA, MAEHAMA T, DIXON JE, DONNER DB: A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci USA 98: 4640-4645, 2001.
76. PANKA DJ, MANO T, SUHARA T, WALSH K, MIER JW: Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem 276: 6893-6896, 2001.
77. PERALDI P, XU M, SPIEGELMAN BM: Thiazolidinediones block tumor necrosis factor-α-induced inhibition of insulin signaling. J Clin Invest 100: 1863-1869, 1997.
78. RENA G, GUO S, CICHY SC, UNTERMAN TG, COHEN P: Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183, 1999.
79. ROMASHKOVA JA, MAKAROV SS: NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90, 1999.
80. RONDINONE CM, CARVALHO E, WESSLAU C, SMITH UP: Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus. Diabetologia 42: 819-825, 1999.
81. SATO S, FUJITA N, TSURUO T: Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832-10837, 2000.
82. SCHLEICHER ED, WEIGERT C: Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int 58 (Suppl 77): S13-S18, 2000.
83. SCHNYDER B, PITTET M, DURAND J, SCHNYDER-CANDRIAN S: Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport. Am J Physiol 282: E87-E94, 2002.
84. KIP1. J Biol Chem 276: 40687-40692, 2001.
85. SCOTT PH, BRUNN GJ, KOHN AD, ROTH RA, LAWRENCE JC, Jr: Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci USA 95: 7772-7777, 1998.
86. SHANKLAND SJ, WOLF G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol 278: F515-529, 2000.
87. SHIN I, YAKES FM, ROJO F, SHIN NY, BAKIN AV, BASELGA J, ARTEAGA CL: PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8: 1145-1152, 2002.
88. SHIOJIMA I, WALSH K: Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250, 2002.
89. SONG XM, KAWANO Y, KROOK A, RYDER JW, EFENDIC S, ROTH RA, WALLBERG-HENRIKSSON H, ZIERATH JR: Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Diabetes 48: 664-670, 1999.
90. STAAL SP: Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 84: 5034-5037, 1987.
91. STORGAARD H, SONG XM, JENSEN CB, MADSBAD S, BJORNHOLM M, VAAG A, ZIERATH JR: Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients. Diabetes 50: 2770-2778, 2001.
92. SUN XJ, ROTHENBERG P, KAHN CR, BACKER JM, ARAKI E, WILDEN PA, CAHILL DA, GOLDSTEIN BJ, WHITE MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-17, 1991.
93. SUN XJ, WANG LM, ZHANG Y, YENUSH L, MYERS MGJ, GLASHEEN E, LANE WS, PIERCE JH, WHITE MF: Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173-177, 1995.
94. TAMAROGLIO TA, LO CS: Regulation of fibronectin by insulin-like growth factor-I in cultured rat thoracic aortic smooth muscle cells and glomerular mesangial cells. Exp Cell Res 215: 338-346, 1994.
95. TERUEL T, HERNANDEZ R, LORENZO M: Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50: 2563-2571, 2001.
96. TESTA JR, BELLACOSA A: AKT plays a central role in tumorigenesis. [comment]. Proc Natl Acad Sci USA 98: 10983-10985, 2001.
97. THIRONE AC, SCARLETT JA, GASPARETTI AL, ARAUJO EP, LIMA MH, CARVALHO CR, VELLOSO LA, SAAD MJ: Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes 51: 2270-2281, 2002.
98. THOMAS SR, CHEN K, KEANEY JF: Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277: 6017-6024, 2002.
99. TIROSH A, POTASHNIK R, BASHAN N, RUDICH A: Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602, 1999.
100. TOKER A, CANTLEY LC: Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676, 1997.
101. TREASURE CB, KLEIN JL, WEINTRAUB WS, TALLEY JD, STILLABOWER ME, KOSINSKI AS, ZHANG J, BOCCUZZI SJ, CEDARHOLM JC, ALEXANDER RW: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332: 481-487, 1995.
102. TREMBLAY F, LAVIGNE C, JACQUES H, MARETTE A: Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (/) activities. Diabetes 50: 1901-1910, 2001.
103. TUTTLE RL, GILL NS, PUGH W, LEE JP, KOEBERLEIN B, FURTH EE, POLONSKY KS, NAJI A, BIRNBAUM MJ: Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 7: 1133-1137, 2001.
104. VECCHIONE C, MAFFEI A, COLELLA S, ARETINI A, POULET R, FRATI G, GENTILE MT, FRATTA L, TRIMARCO V, TRIMARCO B, LEMBO G: Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51: 168-173, 2002.
105. WEN S, STOLAROV J, MYERS MP, SU JD, WIGLER MH, TONKS NK, DURDEN DL: PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA 98: 4622-4627, 2001.
106. WOLF G: Cell cycle regulation in diabetic nephropathy. Kidney Int 58 (Suppl 77): S59-S66, 2000.
107. XIAO GH, JEFFERS M, BELLACOSA A, MITSUUCHI Y, VANDE WOUDE GF, TESTA JR: Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 98: 247-252, 2001.
108. ŽDYCHOVÁ J, PELIKÁNOVÁ T, KAZDOVÁ L, KOMERS R: Renal cortical expression of Akt and PTEN in Zucker diabetic fatty rats. Diabetes Metab 29: 4S297 (abstract), 2003.
109. ZENG G, QUON MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996.
110. ZENG G, NYSTROM FH, RAVICHANDRAN LV, CONG LN, KIRBY M, MOSTOWSKI H, QUON MJ: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101: 1539-1545, 2000.
111. ZHOU BP, LIAO Y, XIA W, SPOHN B, LEE MH, HUNG MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252, 2001.